Maurizio Rossini Selected Research

6- amino- 1- hydroxyhexane- 1,1- diphosphonate

1/2021	Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study.
3/2013	Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study.
1/2013	Clinical development of neridronate: potential for new applications.
7/2011	Long-term effects of neridronate and its discontinuation in patients with primary hyperparathyroidism.
11/2008	Intramuscular neridronate in postmenopausal women with low bone mineral density.
5/2005	Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maurizio Rossini Research Topics

Disease

33	Rheumatoid Arthritis 04/2022 - 01/2010
32	Osteoporosis 04/2022 - 11/2008
12	Postmenopausal Osteoporosis 01/2017 - 08/2005
8	Vitamin D Deficiency 12/2021 - 12/2004
7	COVID-19 11/2022 - 01/2021
6	Pain (Aches) 01/2022 - 07/2009
6	Ankylosing Spondylitis 11/2018 - 01/2014
6	Bone Resorption 01/2017 - 09/2011
5	Arthritis (Polyarthritis) 04/2022 - 06/2011
5	Psoriatic Arthritis 03/2020 - 01/2018
5	Systemic Mastocytosis 01/2018 - 02/2014
5	Osteogenesis Imperfecta (Lobstein Disease) 11/2013 - 06/2004
4	Neoplasms (Cancer) 11/2021 - 06/2012
4	Mastocytosis 01/2017 - 05/2014
4	Acute-Phase Reaction 11/2014 - 01/2012
3	Systemic Scleroderma (Systemic Sclerosis) 10/2022 - 01/2019
3	Metabolic Bone Diseases (Osteopenia) 12/2021 - 11/2008
3	Hypertension (High Blood Pressure) 11/2021 - 06/2012
3	Inflammation (Inflammations) 03/2020 - 10/2016
3	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2020 - 04/2015
3	Adult-Onset Still's Disease 01/2020 - 01/2017
3	Vascular Calcification 08/2019 - 02/2016
3	Anorexia Nervosa 01/2017 - 04/2007
3	Body Weight (Weight, Body) 06/2011 - 04/2007
2	Rheumatic Diseases (Rheumatism) 11/2022 - 03/2020
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 01/2018
2	Secondary Hyperparathyroidism 12/2021 - 01/2017
2	Diabetes Mellitus 12/2021 - 08/2019
2	Exanthema (Rash) 07/2021 - 01/2019
2	Overweight 04/2021 - 10/2019
2	Infections 01/2021 - 01/2019
2	Atherosclerosis 01/2020 - 11/2017
2	Insulin Resistance 10/2019 - 02/2016
2	Bone Diseases (Bone Disease) 01/2018 - 07/2011
2	Chronic Renal Insufficiency 01/2018 - 01/2017
2	Osteitis Deformans (Paget's Disease of Bone) 04/2017 - 01/2013
2	Vitamin K Deficiency 01/2017 - 02/2016
2	Hypersensitivity (Allergy) 07/2015 - 09/2011
2	Knee Osteoarthritis 02/2015 - 07/2009
2	Primary Hyperparathyroidism 04/2013 - 07/2011
2	Reflex Sympathetic Dystrophy (Reflex Sympathetic Dystrophy Syndrome) 03/2013 - 01/2013
1	Musculoskeletal Diseases (Musculoskeletal Disease) 11/2022

Drug/Important Bio-Agent (IBA)

24	Diphosphonates (Bisphosphonates)IBA 01/2022 - 08/2005
20	Vitamin D FDA LinkGeneric 04/2022 - 12/2004
11	GlucocorticoidsIBA 11/2022 - 06/2011
8	Biological ProductsIBA 07/2021 - 08/2014
7	Pharmaceutical PreparationsIBA 04/2022 - 07/2009
7	Parathyroid Hormone (Parathormone)IBA 01/2021 - 06/2011
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2007
6	6- amino- 1- hydroxyhexane- 1,1- diphosphonateIBA 01/2021 - 05/2005
5	Methotrexate (Mexate)FDA LinkGeneric 04/2022 - 08/2014
5	CalciumIBA 12/2021 - 06/2011
5	Denosumab FDA Link 01/2017 - 11/2012
5	Zoledronic Acid (Zometa)FDA Link 11/2014 - 01/2012
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 03/2010
4	MineralsIBA 12/2021 - 06/2011
4	Cholecalciferol (Vitamin D3)FDA Link 07/2021 - 01/2018
4	Teriparatide (Parathar)FDA Link 01/2018 - 05/2011
4	Tryptases (Tryptase)IBA 03/2016 - 10/2011
3	Interleukin-1 (Interleukin 1)IBA 07/2021 - 01/2017
3	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 07/2021 - 01/2019
3	Antirheumatic Agents (DMARD)IBA 01/2021 - 08/2014
3	OsteocalcinIBA 08/2019 - 04/2007
3	Vitamin K FDA Link 08/2019 - 02/2016
3	CateninsIBA 04/2017 - 08/2013
3	Collagen Type I (Type I Collagen)IBA 04/2017 - 04/2012
3	collagen type I trimeric cross-linked peptideIBA 04/2017 - 03/2012
3	hydroxide ionIBA 09/2015 - 01/2010
3	Clodronic Acid (Clodronate)IBA 02/2015 - 07/2009
3	Ibandronic Acid (Boniva)FDA Link 07/2013 - 07/2009
2	Rituximab (Mabthera)FDA Link 04/2022 - 03/2017
2	Environmental Pollutants (Pollutants, Environmental)IBA 01/2022 - 07/2021
2	Antidepressive Agents (Antidepressants)IBA 01/2022 - 07/2014
2	Air Pollutants (Pollutants, Air)IBA 01/2022 - 10/2021
2	Carbon MonoxideIBA 01/2022 - 05/2020
2	belimumabIBA 11/2021 - 01/2020
2	CreatinineIBA 11/2021 - 11/2017
2	Janus KinasesIBA 07/2021 - 03/2020
2	Estrogens (Estrogen)FDA Link 01/2021 - 01/2013
2	25-hydroxyvitamin DIBA 01/2021 - 01/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 10/2016
2	InterleukinsIBA 01/2020 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 08/2019 - 02/2016
2	Etanercept (Enbrel)FDA Link 01/2019 - 11/2013
2	CytokinesIBA 01/2019 - 03/2014
2	Monoclonal AntibodiesIBA 01/2017 - 01/2017
2	Tumor Necrosis Factor InhibitorsIBA 10/2016 - 06/2016
2	Phosphates (Orthophosphate)IBA 06/2016 - 05/2008
2	Hormones (Hormone)IBA 10/2015 - 01/2013
2	Saline SolutionIBA 02/2015 - 11/2014
2	Analgesics (Analgesic Drugs)IBA 07/2014 - 03/2010
2	Infliximab (Remicade)FDA Link 01/2014 - 11/2013
2	NitrogenIBA 07/2013 - 01/2012
2	Conjugated (USP) Estrogens (Premarin)FDA Link 07/2013 - 01/2013
2	bazedoxifeneIBA 07/2013 - 01/2013
1	COVID-19 VaccinesIBA 10/2022
1	Janus Kinase InhibitorsIBA 04/2022

Therapy/Procedure

18	Therapeutics 11/2022 - 08/2005
5	Aftercare (After-Treatment) 01/2022 - 07/2011
2	Renal Dialysis (Hemodialysis) 08/2019 - 02/2016